Neovasc enters collaboration & licensing pact with Penn Medicine and the Gorman Cardiovascular Research Group

Neovasc Inc., a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, has entered into a collaboration and licensing agreement relating to certain know─how

More From BioPortfolio on "Neovasc enters collaboration & licensing pact with Penn Medicine and the Gorman Cardiovascular Research Group"